Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cellebrite DI (CLBT) Operating Leases (2022 - 2025)

Cellebrite DI's Operating Leases history spans 4 years, with the latest figure at $18.7 million for Q4 2025.

  • Quarterly Operating Leases rose 172.85% to $18.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $18.7 million through Dec 2025, up 172.85% year-over-year, with the annual reading at $18.7 million for FY2025, 172.85% up from the prior year.
  • Operating Leases came in at $18.7 million for Q4 2025, up from $6.8 million in the prior quarter.
  • In the past five years, Operating Leases ranged from a high of $18.7 million in Q4 2025 to a low of $6.8 million in Q4 2024.
  • The 4-year median for Operating Leases is $9.8 million (2022), against an average of $11.3 million.
  • Year-over-year, Operating Leases decreased 25.26% in 2024 and then soared 172.85% in 2025.
  • Cellebrite DI's Operating Leases stood at $10.4 million in 2022, then fell by 11.55% to $9.2 million in 2023, then fell by 25.26% to $6.8 million in 2024, then skyrocketed by 172.85% to $18.7 million in 2025.
  • Per Business Quant, the three most recent readings for CLBT's Operating Leases are $18.7 million (Q4 2025), $6.8 million (Q4 2024), and $9.2 million (Q4 2023).